Current status of composite tissue allotransplantation

Area of Science:

• Regenerative Medicine
• Transplantation Immunology
• Surgical Innovation

Background:

• Composite tissue allotransplantation (CTA) presents a promising approach for reconstructing extensive tissue defects.
• Lifelong immunosuppression remains a significant challenge, impacting patient outcomes and treatment feasibility.
• The field has evolved with numerous experimental models since the first clinical hand transplant in 1998.

Purpose of the Study:

• To provide a historical overview of composite tissue allotransplantation (CTA).
• To discuss the evolution of experimental CTA models in transplantation research.
• To present the authors' experience with various CTA models.

Main Methods:

• Literature review of historical milestones in CTA.
• Analysis of experimental CTA models in preclinical research.
• Retrospective review of institutional experience in CTA.

Main Results:

• The historical progression of CTA from experimental stages to clinical application is detailed.
• Various experimental models have contributed to understanding CTA challenges and potential solutions.
• The authors' experience provides insights into the practical aspects of implementing CTA.

Conclusions:

• CTA holds significant potential for treating complex tissue loss.
• Addressing the need for immunosuppression is critical for widespread clinical adoption.
• Continued research in CTA models is essential for advancing the field.